Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels

NCT04539301 · clinicaltrials.gov ↗

RECRUITING

Status

2100

Enrollment

OTHER

Sponsor class

Conditions

Anticoagulation
Venous Thromboembolism
Atrial Fibrillation

Interventions

DIAGNOSTIC_TEST: Estimated anticoagulant level (conversion factor x anti-Xa activity)

Sponsor

Nantes University Hospital